RVRCOTCPharmaceutical PreparationsFiscal year ends December 31
Revium Rx.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.43+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $86.84M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Revium Rx. has not reported a dividend
No dividend per share appears in Revium Rx.'s annual filings since fiscal 2024.